MedPath

Poliovirus type 3 antigen (formaldehyde inactivated)

Generic Name
Poliovirus type 3 antigen (formaldehyde inactivated)
Brand Names
Ipol, Kinrix, Pediarix, Pentacel, Quadracel, Vaxelis
Drug Type
Biotech
Unique Ingredient Identifier
459ROM8M9M

Overview

Poliovirus type 3 antigen is a suspension of poliovirus Type 3 (Saukett) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 3. The vaccine contains purified and inactivated poliovirus type 3 that were grown from a continuous line of monkey kidney cells.

Background

Poliovirus type 3 antigen is a suspension of poliovirus Type 3 (Saukett) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 3. The vaccine contains purified and inactivated poliovirus type 3 that were grown from a continuous line of monkey kidney cells.

Indication

No indication information available.

Associated Conditions

  • Poliomyelitis caused by Poliovirus
  • Poliomyelitis caused by poliovirus type 1

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

IMOVAX POLIO INJECTION
Manufacturer:SANOFI PASTEUR
Form:INJECTION
Strength:8 D.U./0.5 mL
Online:Yes
Approved: 1999/01/06
Approval:SIN10608P
ADACEL®-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
Manufacturer:Sanofi Pasteur (VDR), SANOFI PASTEUR LIMITED
Form:INJECTION, SUSPENSION
Strength:8 D-antigen units
Online:Yes
Approved: 2018/05/08
Approval:SIN15479P
ADACEL®-POLIO SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
Manufacturer:Sanofi Pasteur (VDR), SANOFI PASTEUR LIMITED
Form:INJECTION, SUSPENSION
Strength:32 D-antigen units
Online:Yes
Approved: 2018/05/08
Approval:SIN15479P
HEXAXIM SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE
Manufacturer:Sanofi Pasteur Val de Reuil
Form:INJECTION, SUSPENSION
Strength:32 DU/0.5 mL
Online:Yes
Approved: 2015/08/25
Approval:SIN14834P
INFANRIX HEXA VACCINE
Manufacturer:GLAXOSMITHKLINE BIOLOGICALS SA, GlaxoSmithKline Biologicals, GSK Biologicals SA
Form:INJECTION
Strength:32 du/0.5 ml
Online:Yes
Approved: 2003/05/07
Approval:SIN12288P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath